Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Prognostic impact of Ki-67 proliferative index in resectable pancreatic ductal adenocarcinoma.

Pergolini I, Crippa S, Pagnanelli M, Belfiori G, Pucci A, Partelli S, Rubini C, Castelli P, Zamboni G, Falconi M.

BJS Open. 2019 May 10;3(5):646-655. doi: 10.1002/bjs5.50175. eCollection 2019 Oct.

2.

Reappraisal of a 2-Cm Cut-Off Size for the Management of Cystic Pancreatic Neuroendocrine Neoplasms: A Multicenter International Study.

Maggino L, Schmidt A, Käding A, Westermark S, Ceppa EP, Falconi M, Javed AA, Landoni L, Pergolini I, Perinel J, Vollmer CM Jr, Sund M, Gaujoux S; on the behalf on the Pancreas 2000 research group.

Ann Surg. 2019 Jul 24. doi: 10.1097/SLA.0000000000003508. [Epub ahead of print]

PMID:
31348038
3.

Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions.

Das KK, Geng X, Brown JW, Morales-Oyarvide V, Huynh T, Pergolini I, Pitman MB, Ferrone C, Al Efishat M, Haviland D, Thompson E, Wolfgang C, Lennon AM, Allen P, Lillemoe KD, Fields RC, Hawkins WG, Liu J, Castillo CF, Das KM, Mino-Kenudson M.

Gastroenterology. 2019 Sep;157(3):720-730.e2. doi: 10.1053/j.gastro.2019.05.014. Epub 2019 Jun 5.

PMID:
31175863
4.

Early diagnosis of anastomotic leakage after colorectal surgery by the Dutch leakage score, serum procalcitonin and serum C-reactive protein: study protocol of a prospective multicentre observational study by the Italian ColoRectal Anastomotic Leakage (iC.

Benedetti M, Ciano P, Pergolini I, Ciotti S, Guercioni G, Ruffo G, Borghi F, Patriti A, Del Rio P, Scatizzi M, Mancini S, Garulli G, Carrara A, Pirozzi F, Scabini S, Liverani A, Baiocchi G, Campagnacci R, Muratore A, Longo G, Caricato M, Macarone Palmieri R, Vettoretto N, Ceccaroni M, Guadagni S, Bertocchi E, Cianflocca D, Lambertini M, Pace U, Baraghini M, Pandolfini L, Angeloni R, Lucchi A, Martorelli G, Tirone G, Motter M, Sciuto A, Martino A, Luzzi AP, Di Cesare T, Molfino S, Maurizi A, Marsanic P, Tomassini F, Santoni S, Capolupo GT, Amodio P, Arici E, Clementi M, Ruggeri B, Catarci M.

G Chir. 2019 Jan-Feb;40(1):20-25.

PMID:
30771794
5.

Timing But Not Patterns of Recurrence Is Different Between Node-negative and Node-positive Resected Pancreatic Cancer.

Honselmann KC, Pergolini I, Castillo CF, Deshpande V, Ting D, Taylor MS, Bolm L, Qadan M, Wellner U, Sandini M, Bausch D, Warshaw AL, Lillemoe KD, Keck T, Ferrone CR.

Ann Surg. 2019 Jan 18. doi: 10.1097/SLA.0000000000003123. [Epub ahead of print]

PMID:
30672796
6.

Correction: Long-term follow-up of low-risk branchduct IPMNs of the pancreas: is main pancreatic duct dilatation the most worrisome feature?

Petrone MC, Magnoni P, Pergolini I, Capurso G, Traini M, Doglioni C, Mariani A, Crippa S, Arcidiacono PG.

Clin Transl Gastroenterol. 2018 Aug 1;9(7):173. doi: 10.1038/s41424-018-0036-1.

7.

Long-term follow-up of low-risk branch-duct IPMNs of the pancreas: is main pancreatic duct dilatation the most worrisome feature?

Petrone MC, Magnoni P, Pergolini I, Capurso G, Traini M, Doglioni C, Mariani A, Crippa S, Arcidiacono PG.

Clin Transl Gastroenterol. 2018 Jun 13;9(6):158. doi: 10.1038/s41424-018-0026-3. Erratum in: Clin Transl Gastroenterol. 2018 Aug 1;9(7):173.

8.

Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX.

Michelakos T, Pergolini I, Castillo CF, Honselmann KC, Cai L, Deshpande V, Wo JY, Ryan DP, Allen JN, Blaszkowsky LS, Clark JW, Murphy JE, Nipp RD, Parikh A, Qadan M, Warshaw AL, Hong TS, Lillemoe KD, Ferrone CR.

Ann Surg. 2019 Apr;269(4):733-740. doi: 10.1097/SLA.0000000000002600.

PMID:
29227344
9.

Systematic review and meta-analysis of prognostic role of splenic vessels infiltration in resectable pancreatic cancer.

Crippa S, Cirocchi R, Maisonneuve P, Partelli S, Pergolini I, Tamburrino D, Aleotti F, Reni M, Falconi M.

Eur J Surg Oncol. 2018 Jan;44(1):24-30. doi: 10.1016/j.ejso.2017.10.217. Epub 2017 Nov 20. Review.

PMID:
29183639
10.

Intraductal Papillary Mucinous Neoplasm of the Pancreas in Young Patients: Tumor Biology, Clinical Features, and Survival Outcomes.

Morales-Oyarvide V, Mino-Kenudson M, Ferrone CR, Warshaw AL, Lillemoe KD, Sahani DV, Pergolini I, Attiyeh MA, Al Efishat M, Rezaee N, Hruban RH, He J, Weiss MJ, Allen PJ, Wolfgang CL, Fernández-Del Castillo C.

J Gastrointest Surg. 2018 Feb;22(2):226-234. doi: 10.1007/s11605-017-3602-z. Epub 2017 Oct 18.

PMID:
29047068
11.

SUVmax after (18)fluoro-deoxyglucose positron emission tomography/computed tomography: A tool to define treatment strategies in pancreatic cancer.

Pergolini I, Crippa S, Salgarello M, Belfiori G, Partelli S, Ruffo G, Pucci A, Zamboni G, Falconi M.

Dig Liver Dis. 2018 Jan;50(1):84-90. doi: 10.1016/j.dld.2017.09.122. Epub 2017 Sep 22.

PMID:
29017830
12.

Diabetes mellitus in intraductal papillary mucinous neoplasm of the pancreas is associated with high-grade dysplasia and invasive carcinoma.

Morales-Oyarvide V, Mino-Kenudson M, Ferrone CR, Sahani DV, Pergolini I, Negreros-Osuna AA, Warshaw AL, Lillemoe KD, Fernández-Del Castillo C.

Pancreatology. 2017 Nov - Dec;17(6):920-926. doi: 10.1016/j.pan.2017.08.073. Epub 2017 Sep 8.

PMID:
28890154
13.

Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival.

Pergolini I, Morales-Oyarvide V, Mino-Kenudson M, Honselmann KC, Rosenbaum MW, Nahar S, Kem M, Ferrone CR, Lillemoe KD, Bardeesy N, Ryan DP, Thayer SP, Warshaw AL, Fernández-Del Castillo C, Liss AS.

PLoS One. 2017 Aug 30;12(8):e0182855. doi: 10.1371/journal.pone.0182855. eCollection 2017.

14.

Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.

Pergolini I, Sahora K, Ferrone CR, Morales-Oyarvide V, Wolpin BM, Mucci LA, Brugge WR, Mino-Kenudson M, Patino M, Sahani DV, Warshaw AL, Lillemoe KD, Fernández-Del Castillo C.

Gastroenterology. 2017 Nov;153(5):1284-1294.e1. doi: 10.1053/j.gastro.2017.07.019. Epub 2017 Jul 21.

PMID:
28739282
15.

Reappraisal of Staging Laparoscopy for Patients with Pancreatic Adenocarcinoma: A Contemporary Analysis of 1001 Patients.

Fong ZV, Alvino DML, Fernández-Del Castillo C, Mehtsun WT, Pergolini I, Warshaw AL, Chang DC, Lillemoe KD, Ferrone CR.

Ann Surg Oncol. 2017 Oct;24(11):3203-3211. doi: 10.1245/s10434-017-5973-5. Epub 2017 Jul 17.

PMID:
28718038
16.

Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Al Efishat MA, Attiyeh MA, Eaton AA, Gönen M, Prosser D, Lokshin AE, Castillo CF, Lillemoe KD, Ferrone CR, Pergolini I, Mino-Kenudson M, Rezaee N, Dal Molin M, Weiss MJ, Cameron JL, Hruban RH, D'Angelica MI, Kingham TP, DeMatteo RP, Jarnagin WR, Wolfgang CL, Allen PJ.

Ann Surg. 2018 Aug;268(2):340-347. doi: 10.1097/SLA.0000000000002421.

17.

Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy.

Yang KS, Im H, Hong S, Pergolini I, Del Castillo AF, Wang R, Clardy S, Huang CH, Pille C, Ferrone S, Yang R, Castro CM, Lee H, Del Castillo CF, Weissleder R.

Sci Transl Med. 2017 May 24;9(391). pii: eaal3226. doi: 10.1126/scitranslmed.aal3226.

18.

Defining the Need for Surgery in Small-Bowel Obstruction.

Kuehn F, Weinrich M, Ehmann S, Kloker K, Pergolini I, Klar E.

J Gastrointest Surg. 2017 Jul;21(7):1136-1141. doi: 10.1007/s11605-017-3418-x. Epub 2017 Apr 13.

PMID:
28409293
19.

Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.

Attiyeh MA, Fernández-Del Castillo C, Al Efishat M, Eaton AA, Gönen M, Batts R, Pergolini I, Rezaee N, Lillemoe KD, Ferrone CR, Mino-Kenudson M, Weiss MJ, Cameron JL, Hruban RH, D'Angelica MI, DeMatteo RP, Kingham TP, Jarnagin WR, Wolfgang CL, Allen PJ.

Ann Surg. 2018 Jan;267(1):157-163. doi: 10.1097/SLA.0000000000002015.

20.

Risk of misdiagnosis and overtreatment in patients with main pancreatic duct dilatation and suspected combined/main-duct intraductal papillary mucinous neoplasms.

Crippa S, Pergolini I, Rubini C, Castelli P, Partelli S, Zardini C, Marchesini G, Zamboni G, Falconi M.

Surgery. 2016 Apr;159(4):1041-9. doi: 10.1016/j.surg.2015.11.003. Epub 2015 Dec 17.

PMID:
26704784
21.

Skeletal muscle metastases as initial presentation of gastric carcinoma.

Pergolini I, Crippa S, Santinelli A, Marmorale C.

Am J Case Rep. 2014 Dec 28;15:580-3. doi: 10.12659/AJCR.891397.

22.

[Cervical cerclage and evidence-based medicine: if, how and when].

Patella A, Pergolini I, Custo G, Rech F.

Minerva Ginecol. 2007 Apr;59(2):191-8. Review. Italian.

PMID:
17505461
23.

Three-dimensional sonography and hysterosalpingosonography in the diagnosis of uterine anomalies.

La Torre R, Prosperi Porta R, Franco C, Sansone M, Mazzocco M, Pergolini I, De Felice C, Cosmi EV.

Clin Exp Obstet Gynecol. 2003;30(4):190-2.

PMID:
14664407

Supplemental Content

Loading ...
Support Center